The Future of Falsified and Substandard Medicine Detection: Digital Methods To Track and Authenticate Pharmaceutical Products
This case study and associated publications (Naughton et al., 2017, 2016) paint a picture of a technically sound, planned digital solutions to address the problem presented by substandard and falsified medicines, which appear to be growing internationally, particularly as purchases increasingly take...
Yazar: | Naughton, B |
---|---|
Materyal Türü: | Record |
Baskı/Yayın Bilgisi: |
Pathways for Prosperity Commission
2018
|
Benzer Materyaller
-
Trade in substandard and falsified medicines
Yazar:: Hagen, N, ve diğerleri
Baskı/Yayın Bilgisi: (2022) -
Substandard and Falsified Medicines in Myanmar
Yazar:: Mirai Sakuda, ve diğerleri
Baskı/Yayın Bilgisi: (2020-03-01) -
Identification of substandard and falsified medicines: influence of different tolerance limits and use of authenticity inquiries
Yazar:: Hauk, C, ve diğerleri
Baskı/Yayın Bilgisi: (2021) -
How to achieve international action on falsified and substandard medicines.
Yazar:: Attaran, A, ve diğerleri
Baskı/Yayın Bilgisi: (2012) -
Substandard and Falsified Medicines: Proposed Methods for Case Finding and Sentinel Surveillance
Yazar:: Elizabeth Pisani, ve diğerleri
Baskı/Yayın Bilgisi: (2021-08-01)